Really proud to have led the effort with #T1DI to use existing data to uncover underlying questions in #T1D. In our latest paper, we used the data to determine the optimal ages to screen with the goal to use this approach as an entry into public health screening for T1D.

Obesity continues to be on the rise in the US, including among those with type 1 diabetes. Could the microbiome be playing a role and if so, can we modulate that? Check out our new review article, hot off the press!! frontiersin.org/articles/10.33…

Starting the day off strong Center for Diabetes and Metabolic Diseases symposium with an exciting talk by the Dr Jane Reusch #IUCDMD2022 #diabetes #exerciseiskey

What’s up with T1D heterogeneity, you ask? Emily K. Sims is gonna tell us @ #IUCDMD2022

Continuing the Center for Diabetes and Metabolic Diseases #IUCDMD2022 Symposium with a discussion of beta cell function during T1D pathogenesis from the talented Emily K. Sims

Happy to present some data of my project at 8th Annual Diabetes Symposium. I am very thankful for my mentor Dr. Erica Cai and my collaborators. Center for Diabetes and Metabolic Diseases

Congratulations to Olha Melnyk 🇺🇦 on a very well deserved abstract award for her work she will present at the upcoming HIRN meeting!

Please consider answering this survey if you are a woman scientist in #diabetes! #niddk the(sugar)science Center for Diabetes and Metabolic Diseases DiabDocs-K12 Dr. Jessica Dunne Barbara Corkey Emily K. Sims Heba @DarleenSandoval Durga Singer #WomenInSTEM @mhill226 Jamie Felton Amelia Linnemann, Ph.D.

Please join us in thanking the co-chairs of the HIRN 2022 Annual Investigator Meeting - Drs. Holger Russ, Amelia Linnemann, Sangeeta Dhawan and Katie Coate. They provided scientific guidance, leadership and oversight in the meeting planning process. #HIRN2022

⁦⁦John Dennis⁩ kicking off his #easd2022 rising star award, amazing research on treatment of t2d, and the chair also mentioned his exceptionally good haircut ExeterDiabetes⁩

Way overdue but never too late I guess…during the early part of the pandemic and shutdown, everyone was struggling. As a full time single mom of a 3 and 6 yo at the time, and a full time researcher and physician, itching to see patients and also do research, I had a lot to say.

Happy and honored to be invited to share the stage with Dr. CR Kahn and 12 nationally identified early-career research scholars at the upcoming 2022 Rising Stars Symposium University of Kentucky College of Medicine University of Kentucky I will be talking about #m6A, #T2D, and #betacells. Registration closes today

Exciting opportunity to join the new NIHR Biomedical Research Centre in Exeter as a Senior Research Technician to work with a multidisciplinary team of clinicians and scientists with expertise in diabetes and neuroscience University of Exeter Faculty of Health & Life Sci ExeterDiabetes jobs.exeter.ac.uk/hrpr_webrecrui…

Congratulations to Becca Davidson, PhD 🏳️‍🌈 on a wonderful thesis defense seminar, and congrats to Jason Spaeth on some excellent mentoring!

We're still buzzing with excitement over the good news! ICYMI: Our IU School of Medicine researchers with Type 1 Diabetes TrialNet helped contribute to the first FDA-approved drug to delay the onset of #Type1Diabetes. medicine.iu.edu/news/2022/11/t…

Strong #mentorship is integral to our daily efforts! Check out the latest IU School of Medicine blog for a glimpse into what makes our Center for Diabetes and Metabolic Diseases team so special. #DiabetesAwarenessMonth Evans-MolinaLab Dr. Carmella EvansMolina Emily K. Sims medicine.iu.edu/blogs/research…

Congratulations to Senta for her John Hutton Rising Star Award👏👏👏Last night had the weirdest of dreams…was having a drink with John Hutton and Lelio Orci at “The Langham Tap Room”. While super happy for Senta, they were both lamenting why we don’t have more mentors like Anil!

Risk screening through TrialNet is offered at no cost to eligible individuals to evaluate their personal risk of developing type 1 diabetes. ​ The first step starts with enrolling in the Pathway to Prevention Study at trialnet.org/participate or using the link in our bio!

We had a wonderful holiday celebration last Friday evening! Thank you to all who joined the festivities and Harrison Center for sharing their beautiful space.

Age had no effect on #betacell glucose and insulin sensitivity in antibody-positive individuals progressing to stage 3 #T1D; declining metabolic function was predictable and age independent Dr. Carmella EvansMolina Center for Diabetes and Metabolic Diseases @gabiscavacini #MedTwitter bit.ly/3YgbYrO 🔓